Surgalign Competitors

Summary

SRGADelisted Stock

USD 0.04 0 12.54%

Analyzing Surgalign Holdings competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Surgalign Holdings to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Surgalign Holdings competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
0.03	0.04	0.04

Details

Intrinsic

Valuation

Low	Real	High
0.03	0.03	0.04

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Surgalign Holdings. Your research has to be compared to or analyzed against Surgalign Holdings' peers to derive any actionable benefits. When done correctly, Surgalign Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Surgalign Holdings.

Surgalign Holdings Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Surgalign Holdings and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Surgalign and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Surgalign Holdings does not affect the price movement of the other competitor.

	META	MSFT	UBER	F	T	A	CRM	JPM	MRK	XOM
META		0.28	0.56	-0.01	0.59	0.02	0.66	0.28	-0.55	0.71	META
MSFT	0.28		0.24	0.11	0.18	-0.01	0.01	-0.17	0.12	-0.19	MSFT
UBER	0.56	0.24		-0.03	0.0	0.26	0.03	-0.11	0.05	0.36	UBER
F	-0.01	0.11	-0.03		0.06	-0.38	0.4	0.65	-0.28	0.3	F
T	0.59	0.18	0.0	0.06		-0.5	0.75	0.52	-0.77	0.38	T
A	0.02	-0.01	0.26	-0.38	-0.5		-0.48	-0.64	0.64	-0.01	A
CRM	0.66	0.01	0.03	0.4	0.75	-0.48		0.84	-0.92	0.68	CRM
JPM	0.28	-0.17	-0.11	0.65	0.52	-0.64	0.84		-0.83	0.51	JPM
MRK	-0.55	0.12	0.05	-0.28	-0.77	0.64	-0.92	-0.83		-0.56	MRK
XOM	0.71	-0.19	0.36	0.3	0.38	-0.01	0.68	0.51	-0.56		XOM
	META	MSFT	UBER	F	T	A	CRM	JPM	MRK	XOM

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

High positive correlations

JPM	+ 0.84	CRM
CRM	+ 0.75	T
XOM	+ 0.71	META
XOM	+ 0.68	CRM
CRM	+ 0.66	META
JPM	+ 0.65	F

High negative correlations

MRK	- 0.92	CRM
MRK	- 0.83	JPM
MRK	- 0.77	T
JPM	- 0.64	A
XOM	- 0.56	MRK
MRK	- 0.55	META

Risk-Adjusted Indicators

There is a big difference between Surgalign Stock performing well and Surgalign Holdings Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Surgalign Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
META	1.06	0.02	(0.01)	0.15	1.41	(1.14)	2.62	(3.15)	8.02
MSFT	0.88	(0.08)	(0.07)	0.01	1.51	(0.83)	2.09	(1.85)	8.19
UBER	1.62	(0.12)	(0.05)	0.00	2.25	(1.79)	2.69	(2.44)	20.10
F	1.41	(0.13)	(0.03)	0.03	2.20	(1.39)	2.53	(2.90)	11.21
T	0.92	0.26	0.13	(10.00)	0.86	(1.04)	2.56	(1.72)	6.47
A	1.14	(0.13)	0.00	(0.12)	0.00	0.00	2.29	(2.42)	9.02
CRM	1.28	0.26	0.21	0.35	0.91	(1.51)	3.18	(1.91)	9.09
JPM	1.12	0.00	0.06	0.12	1.44	(1.17)	2.05	(2.00)	15.87
MRK	0.88	(0.24)	0.00	(0.81)	0.00	0.00	2.00	(2.13)	4.89
XOM	1.03	0.00	(0.04)	0.12	1.25	(1.10)	2.14	(2.09)	5.78

Unable to evaluate fundamental data of Surgalign Holdings at this time. Please try again later

All Fundamental Data

Surgalign Holdings Competitive Analysis

The better you understand Surgalign Holdings competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Surgalign Holdings' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Surgalign Holdings' competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	SRGA	GOOG	MSFT	CRM
	12.54 0.04 Surgalign	1.72 169.43 Alphabet	0.43 418.79 Microsoft	0.85 339.11 Salesforce
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady
Market Performance (90 Days Performance)	Very Weak	Insignificant	Weak	Solid
Odds of Financial Distress (Probability Of Bankruptcy)	Dangerous	Very Low	Low	Very Small
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Fairly Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Strong Buy	Strong Buy	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Not Rated	Strong Hold	Strong Hold	Strong Buy
Current Ratio	2.33 X	2.52 X	1.84 X	1.06 X
Net Asset	70.24 M	402.39 B	512.16 B	99.82 B
Profit Margin	(0.65) %	0.28 %	0.36 %	0.15 %
EBITDA	(68.28 M)	97.97 B	133.01 B	9.22 B
Operating Margin	(0.68) %	0.32 %	0.47 %	0.20 %
Current Valuation	(7.93 M)	2 T	3.1 T	322.95 B
Price To Book	1.79 X	6.49 X	10.82 X	5.63 X
Retained Earnings	(624.22 M)	211.25 B	173.14 B	11.72 B
Current Asset	N/A	105.41 B	139.66 B	4.35 B
Five Year Return	N/A	N/A	1.18 %	N/A
Beta	1.8	1.03	0.9	1.29
Number Of Employees	217	181.27 K	228 K	72.68 K
Shares Outstanding	9.18 M	5.53 B	7.43 B	956 M
Cash Flow From Operations	(52.11 M)	101.75 B	118.55 B	10.23 B
Annual Yield	N/A	0 %	0.01 %	0 %
Total Debt	10.19 M	28.5 B	97.85 B	13.56 B
Return On Equity	-14.97	0.32	0.36	0.0973
Z Score	-13.78	N/A	N/A	N/A
Return On Asset	-0.35	0.16	0.15	0.0471
Number Of Shares Shorted	65.91 K	40.44 M	62.52 M	13.15 M
Book Value Per Share	(2.08) X	25.61 X	38.69 X	60.16 X
Current Liabilities	N/A	16.76 B	59.36 B	5.62 B
Total Asset	70.24 M	402.39 B	512.16 B	99.82 B
Debt To Equity	0.54 %	0.12 %	0.44 %	0.24 %
Short Ratio	0.77 X	2.40 X	3.28 X	3.22 X
Target Price	2.25	204.93	504.77	345.65
Last Dividend Paid	N/A	0.4	3.08	0.8
Shares Owned By Institutions	23.05 %	61.41 %	73.55 %	82.35 %
Market Capitalization	1.68 M	2.06 T	3.11 T	324.19 B
Price To Earnings To Growth	(0.02) X	1.04 X	2.21 X	2.34 X
Price To Earning	N/A	20.62 X	26.64 X	291.69 X
Price To Sales	0.25 X	6.07 X	12.25 X	8.89 X
Net Income	(54.6 M)	73.8 B	88.14 B	4.14 B
Earnings Per Share	(8.12) X	7.55 X	12.09 X	5.75 X
Shares Owned By Insiders	17.15 %	0.02 %	0.06 %	2.63 %
Revenue	81.98 M	307.39 B	245.12 B	34.86 B
Working Capital	35.56 M	89.72 B	34.45 B	2.44 B
Cash And Equivalents	29.34 M	116.26 B	34.7 B	7.02 B
Cash Per Share	4.35 X	8.98 X	14.39 X	13.53 X
Gross Profit	40.29 M	156.63 B	165.36 B	22.99 B
Day Typical Price	0.0337	169.1	418.24	341.75
Accumulation Distribution	0.11	0.018	0.0147	0.0275
Market Facilitation Index	0.0039	3.06	6.19	9.56
Daily Balance Of Power	1.0	0.9346	0.2892	(0.30)
Period Momentum Indicator	0.0039	2.86	1.79	(2.91)
Rate Of Daily Change	1.13	1.02	1.0	0.99
Day Median Price	0.0331	168.93	417.97	343.07
Price Action Indicator	0.0039	1.93	1.72	(5.41)
Coefficient Of Variation	(433.53)	4878.2	6926.71	426.08
Mean Deviation	8.82	1.2	0.8816	1.28
Jensen Alpha	(3.14)	(0.07)	(0.08)	0.2551
Total Risk Alpha	(5.63)	(0.22)	(0.19)	0.1242
Sortino Ratio	N/A	(0.05)	(0.07)	0.2147
Downside Variance	N/A	3.69	2.39	1.55
Standard Deviation	14.56	1.57	1.27	1.69
Kurtosis	13.2	1.1	7.15	1.75
Potential Upside	11.21	2.21	2.09	3.18
Treynor Ratio	1.71	0.03	0.0117	0.3493
Maximum Drawdown	98.44	8.6	8.19	9.09
Variance	212.1	2.47	1.61	2.85
Market Risk Adjusted Performance	1.72	0.04	0.0217	0.3593
Risk Adjusted Performance	(0.17)	0.0208	0.015	0.1848
Skewness	(2.17)	(0.60)	(1.72)	1.01
Semi Deviation	N/A	1.84	1.51	0.9149
Information Ratio	(0.24)	(0.06)	(0.09)	0.1585
Value At Risk	(20.00)	(2.47)	(1.85)	(1.91)
Expected Short fall	N/A	(1.05)	(0.83)	(1.51)
Downside Deviation	N/A	1.92	1.54	1.25
Semi Variance	N/A	3.39	2.28	0.8371

Surgalign Holdings Competition Performance Charts

Five steps to successful analysis of Surgalign Holdings Competition

Surgalign Holdings' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Surgalign Holdings in relation to its competition. Surgalign Holdings' competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Surgalign Holdings in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Surgalign Holdings' competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Surgalign Holdings, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Surgalign Holdings position

In addition to having Surgalign Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Software Thematic Idea Now

Software

Companies that develop and distribute software and software systems to individuals or business. The Software theme has 38 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Software Theme or any other thematic opportunities.

View All Next

Launch

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in Surgalign Stock

If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.

	Stocks Directory Find actively traded stocks across global markets
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC